Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells

Arch Toxicol. 2021 Dec;95(12):3787-3802. doi: 10.1007/s00204-021-03162-5. Epub 2021 Oct 12.

Abstract

Nevadensin, an abundant polyphenol of basil, is reported to reduce alkenylbenzene DNA adduct formation. Furthermore, it has a wide spectrum of further pharmacological properties. The presented study focuses the impact of nevadensin on topoisomerases (TOPO) in vitro. Considering the DNA-intercalating properties of flavonoids, first, minor groove binding properties (IC50 = 31.63 µM), as well as DNA intercalation (IC50 = 296.91 µM) of nevadensin, was found. To determine potential in vitro effects on TOPO I and TOPO IIα, the relaxation and decatenation assay was performed in a concentration range of 1-500 µM nevadensin. A partial inhibition was detected for TOPO I at concentrations ≥ 100 µM, whereas TOPO IIα activity is only inhibited at concentrations ≥ 250 µM. To clarify the mode of action, the isolating in vivo complex of enzyme assay was carried out using human colon carcinoma HT29 cells. After 1 h of incubation, the amount of TOPO I linked to DNA was significantly increased by nevadensin (500 µM), why nevadensin was characterized as TOPO I poison. However, no effects on TOPO IIα were detected in the cellular test system. As a subsequent cellular response to TOPO I poisoning, a highly significant increase of DNA damage after 2 h and a decrease of cell viability after 48 h at the same concentration range were found. Furthermore, after 24 h of incubation a G2/M arrest was observed at concentrations ≥ 100 µM by flow cytometry. The analysis of cell death revealed that nevadensin induces the intrinsic apoptotic pathway via activation of caspase-9 and caspase-3. The results suggest that cell cycle disruption and apoptotic events play key roles in the cellular response to TOPO I poisoning caused by nevadensin in HT29 cells.

Keywords: Caspase activity; Cell cycle arrest; Flavone; Plant polyphenol; Topoisomerase I.

MeSH terms

  • Apoptosis / drug effects*
  • Cell Cycle / drug effects
  • Colonic Neoplasms / enzymology
  • DNA Damage / drug effects*
  • DNA Topoisomerases, Type I / drug effects*
  • DNA Topoisomerases, Type II / drug effects
  • Dose-Response Relationship, Drug
  • Flavones / administration & dosage
  • Flavones / poisoning*
  • HT29 Cells
  • Humans
  • Inhibitory Concentration 50
  • Poly-ADP-Ribose Binding Proteins / drug effects
  • Time Factors

Substances

  • Flavones
  • Poly-ADP-Ribose Binding Proteins
  • nevadensin
  • DNA Topoisomerases, Type I
  • TOP1 protein, human
  • DNA Topoisomerases, Type II
  • TOP2A protein, human